4//SEC Filing
Okajima Masatsune 4
Accession 0001683168-19-000530
CIK 0001226616other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 6:00 AM ET
Size
48.4 KB
Accession
0001683168-19-000530
Insider Transaction Report
Form 4
MEDICINOVA INCMNOV
Okajima Masatsune
VP and Head of Japanese Office
Transactions
- Exercise/Conversion
Common Stock
2019-02-28$3.24/sh+15,000$48,600→ 580,530 total - Exercise/Conversion
Common Stock
2019-02-28$3.09/sh+105,000$324,450→ 685,530 total - Exercise/Conversion
Common Stock
2019-02-28$3.91/sh+30,000$117,300→ 715,530 total - Exercise/Conversion
Common Stock
2019-02-28$6.10/sh+100,000$610,000→ 935,530 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−85,000→ 0 totalExercise: $2.54Exp: 2021-07-12→ Common Stock (85,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−15,000→ 0 totalExercise: $3.24Exp: 2024-12-03→ Common Stock (15,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−105,000→ 0 totalExercise: $3.09Exp: 2025-01-06→ Common Stock (105,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−120,000→ 0 totalExercise: $3.91Exp: 2026-01-06→ Common Stock (120,000 underlying) - Exercise/Conversion
Common Stock
2019-02-28$2.64/sh+105,000$277,200→ 565,530 total - Exercise/Conversion
Common Stock
2019-02-28$7.00/sh+105,000$735,000→ 1,040,530 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−35,700→ 0 totalExercise: $7.34Exp: 2020-01-28→ Common Stock (37,500 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−63,750→ 0 totalExercise: $2.46Exp: 2021-08-02→ Common Stock (63,750 underlying) - Exercise/Conversion
Common Stock
2019-02-28$2.54/sh+85,000$215,900→ 274,280 total - Exercise/Conversion
Common Stock
2019-02-28$2.46/sh+63,750$156,825→ 338,030 total - Exercise/Conversion
Common Stock
2019-02-28$4.10/sh+42,500$174,250→ 460,530 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−42,500→ 0 totalExercise: $4.10Exp: 2023-05-12→ Common Stock (42,500 underlying) - Exercise/Conversion
Common Stock
2019-02-28$4.10/sh+80,000$328,000→ 418,030 total - Exercise/Conversion
Common Stock
2019-02-28$3.91/sh+120,000$469,200→ 835,530 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−80,000→ 0 totalExercise: $4.10Exp: 2023-05-12→ Common Stock (80,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−105,000→ 0 totalExercise: $2.64Exp: 2023-12-11→ Common Stock (105,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−30,000→ 0 totalExercise: $3.91Exp: 2026-01-06→ Common Stock (30,000 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−105,000→ 0 totalExercise: $7.00Exp: 2028-01-05→ Common Stock (105,000 underlying) - Exercise/Conversion
Common Stock
2019-02-28$7.34/sh+35,700$262,038→ 189,280 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2019-02-28−100,000→ 0 totalExercise: $6.10Exp: 2027-01-17→ Common Stock (100,000 underlying)
Footnotes (12)
- [F1]The option vested over a period of 4 years in equal monthly installments from the 1/28/2010 date of grant and is now fully vested.
- [F10]The option was granted on 1/7/2016, was subject to vesting based on achievement of performance criteria and vested in full on 1/18/2017.
- [F11]The option was granted on 1/18/2017, was subject to vesting based on achievement of performance criteria and vested in full on 1/6/2018.
- [F12]The option was granted on 1/6/2018, was subject to vesting based on achievement of performance criteria and vested in full on 1/15/2019.
- [F2]The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested.
- [F3]The option was granted on 8/3/2011, was subject to vesting based on achievement of performance criteria and vested in full on 6/14/2012.
- [F4]The option was granted on 5/13/2013, was subject to vesting based on achievement of performance criteria and vested in full on 12/2/2013.
- [F5]The option vested over a period of 4 years in equal monthly installments from the 5/13/2013 date of grant and is now fully vested.
- [F6]The option was granted on 12/12/2013, was subject to vesting based on achievement of performance criteria and vested in full on 12/4/2014.
- [F7]The option vested over a period of 3 years in equal monthly installments from the 12/4/2014 date of grant and is now fully vested.
- [F8]The option was granted on 1/7/2015, was subject to vesting based on achievement of performance criteria and vested in full on 1/7/2016.
- [F9]The option vested over a period of 3 years in equal monthly installments from the 1/7/2016 date of grant and is now fully vested.
Documents
Issuer
MEDICINOVA INC
CIK 0001226616
Entity typeother
Related Parties
1- filerCIK 0001374660
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 6:00 AM ET
- Size
- 48.4 KB